Morgan Crucible Co PLC
15 January 2007
The Morgan Crucible Company plc
The Company was informed on 4th January 2007 that the Trustees of The Morgan
General Employee Benefit Trust ('the Trust') had transferred 581,225 Ordinary
shares out of the Trust in satisfaction of the exercise of share options
previously granted by the Company under its Sharesave Scheme 2004.
Following this transfer of shares out of the Trust, the Trust holds a total of
10,182,157 Ordinary shares representing 3.47% of the share capital of the
Company. The class of discretionary beneficiaries for whom the Trust holds such
shares consists of employees of the Company including executive directors, Mark
Robertshaw, Kevin Dangerfield and Mark Lejman. Under the provisions of Schedule
13 of the Companies Act 1985 these directors are deemed to be beneficially
interested in all of such shares held by the Trust.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.